Teladoc officer to sell 6,200 shares of stock

Officer Carlos Nueno files a Form 144 to sell 6,200 TDOC shares from vested equity awards, including shares to cover related tax obligations.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer in a Form 144 notice filed for planned sales of its common stock by officer Carlos Nueno. The notice covers a planned sale of 6,200 shares of common stock through Fidelity Brokerage Services LLC on the NYSE.

The securities to be sold arise from restricted stock vesting on September 1, 2026, characterized as compensation from the issuer. A prior sale of 6,196 shares in the last three months is also disclosed. The filer notes that the sale includes shares needed to cover a tax obligation from settlement of a vested equity award.

Key Figures

Planned shares to be sold: 6,200 shares Aggregate market value of planned sale: $39,068.06 Date of restricted stock vesting: September 1, 2026 +3 more

6 metrics

Planned shares to be sold 6,200 shares Common stock of Teladoc Health, Inc. to be sold under Form 144

Aggregate market value of planned sale $39,068.06 Value associated with 6,200 TDOC shares listed for sale

Date of restricted stock vesting September 1, 2026 Vesting date of compensation shares to be sold

Shares sold in past 3 months 6,196 shares TDOC common stock sold on June 2, 2026

Aggregate value of prior sale $47,257.90 Value of 6,196 shares sold on June 2, 2026

Date of notice September 2, 2026 Date the Form 144 notice was filed for TDOC shares

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, equity award distribution

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Carlos Nueno Plana"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

equity award distribution financial

"settlement of a vested equity award distribution."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Teladoc Health, Inc. (TDOC)?

The filing discloses that officer Carlos Nueno plans to sell 6,200 shares of Teladoc Health common stock under Rule 144, with the shares originating from restricted stock vesting on September 1, 2026 and to be sold through Fidelity Brokerage Services LLC.

How many TDOC shares are planned to be sold and at what value?

The notice lists 6,200 shares of Teladoc Health common stock with an aggregate market value of $39,068.06. These are to be sold through Fidelity Brokerage Services LLC and are listed on the NYSE.

What is the source of the Teladoc (TDOC) shares being sold under this Form 144?

The shares come from restricted stock vesting on September 1, 2026. The transaction is classified as Compensation from the issuer, indicating the securities were received as part of an equity award that has now vested.

Were any Teladoc (TDOC) shares sold by this person in the past three months?

Yes. The filing reports that 6,196 shares of Teladoc Health common stock were sold on June 2, 2026 for an aggregate value of $47,257.90 by Carlos Nueno Plana.

Does the Form 144 mention tax obligations related to the TDOC share sale?

Yes. The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating part of the shares are sold to satisfy tax liabilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 03:51 PM EDT Accepted by SEC EDGAR 09/02/2026 - 03:50 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037711
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Nueno Carlos
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6200	39068.06	181684021	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			6200	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carlos Nueno Plana 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	6196	47257.90

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carlos Nueno Plana
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)